"Precision Medicine in Cancer: Will There Be Equitable Benefits?"
Monday, April 8, 2013
2:30 p.m. – 4:30 p.m.
East Hall, Salon C, Walter E. Washington Convention Center
Chair: Drs. Chanita Hughes-Halbert and Rick A. Kittles
Precision Medicine is a systems-based approach in which genomic, cellular and phenotypic information is integrated into clinical care to predict disease risk and outcomes. With more biologically informed strategies for treatment and prevention, less specific indicators of disease process could become obsolete. It is anticipated that precision medicine will lead to improved health outcomes through the delivery of individualized therapy, risk reduction and prevention in all populations. Precision medicine has the potential to reduce and/or eliminate racial disparities in cancer, to the extent that issues related to racial and ethnic background are addressed as part of each component in the pathway of precision medicine. The Minorities in Cancer Research Council (MICR) Forum presented at the 2013 American Association for Cancer Research Annual Meeting will examine the implications of precision medicine on racial disparities in cancer outcomes by critically examining the ways in which race and ethnicity are being addressed in each component of precision medicine.
|
|
Integrating genomic, cellular and phenotypic information to develop personalized cancer medicine
Levi A. Garraway, M.D., Ph.D.
Dana-Farber Cancer Institute, Boston, MA
|
|
|
The role of diversity and systems biology in population-based cancer screening
Rick A. Kittles, Ph.D.
University of Illinois at Chicago, Chicago, IL
|
|
|
Comparative effectiveness research in genomics: Race, ethnicity and clinical considerations
Katrina Armstrong, M.D.
University of Pennsylvania, Philadelphia, PA
|
|
|
Implementation of precision medicine in clinical settings: Patient and provider perspectives
Chanita Hughes-Halbert, Ph.D.
Medical University of South Carolina, Charleston, SC
|
| |
Discussant - The future of preventive medicine: Racial and ethnic considerations
William G. Nelson, M.D.
Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD |
Followed by a panel discussion and Q&A
Back to top